154 related articles for article (PubMed ID: 37859625)
21. MicroRNA-381 inhibits cell proliferation and invasion in endometrial carcinoma by targeting the IGF-1R.
Tu C; Wang F; Wan J
Mol Med Rep; 2018 Mar; 17(3):4090-4098. PubMed ID: 29257334
[TBL] [Abstract][Full Text] [Related]
22. Golgi phosphoprotein 3 (GOLPH3) promotes endometrial carcinoma cell invasion and migration by regulating the epithelial-mesenchymal transition.
Wen Y; Tan X; Wu X; Wu Q; Qin Y; Liang M; Ran G; Gu H; Xie R
Cancer Biomark; 2019; 26(1):21-30. PubMed ID: 31322544
[TBL] [Abstract][Full Text] [Related]
23. KLF9 positively regulates TRIM33 to inhibit abnormal synovial fibroblast proliferation, migration as well as inflammation in rheumatoid arthritis.
Huang D; Tao L; Du X
Immun Inflamm Dis; 2022 Nov; 10(11):e696. PubMed ID: 36301038
[TBL] [Abstract][Full Text] [Related]
24. A Slug-dependent mechanism is responsible for tumor suppression of p53-stabilizing compound CP-31398 in p53-mutated endometrial carcinoma.
Liu L; Yu ZY; Yu TT; Cui SH; Yang L; Chang H; Qu YH; Lv XF; Zhang XA; Ren CC
J Cell Physiol; 2020 Nov; 235(11):8768-8778. PubMed ID: 32633026
[TBL] [Abstract][Full Text] [Related]
25. The BRD4 inhibitor JQ1 suppresses tumor growth by reducing c-Myc expression in endometrial cancer.
Pang Y; Bai G; Zhao J; Wei X; Li R; Li J; Hu S; Peng L; Liu P; Mao H
J Transl Med; 2022 Jul; 20(1):336. PubMed ID: 35902869
[TBL] [Abstract][Full Text] [Related]
26. Estrogen inhibits autophagy and promotes growth of endometrial cancer by promoting glutamine metabolism.
Zhou WJ; Zhang J; Yang HL; Wu K; Xie F; Wu JN; Wang Y; Yao L; Zhuang Y; Xiang JD; Zhang AJ; He YY; Li MQ
Cell Commun Signal; 2019 Aug; 17(1):99. PubMed ID: 31429768
[TBL] [Abstract][Full Text] [Related]
27. CircZNF124 regulates cell proliferation, leucine uptake, migration and invasion by miR-199b-5p/SLC7A5 pathway in endometrial cancer.
Shu L; Peng Y; Zhong L; Feng X; Qiao L; Yi Y
Immun Inflamm Dis; 2021 Dec; 9(4):1291-1305. PubMed ID: 34145797
[TBL] [Abstract][Full Text] [Related]
28. The role of the SDF-1/ CXCR7 axis on the growth and invasion ability of endometrial cancer cells.
Gu HQ; Zhang ZB; Zhang JW; Wang QQ; Xi XW; He YY
Arch Gynecol Obstet; 2017 Apr; 295(4):987-995. PubMed ID: 28239742
[TBL] [Abstract][Full Text] [Related]
29. TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.
Chen M; Lingadahalli S; Narwade N; Lei KMK; Liu S; Zhao Z; Zheng Y; Lu Q; Tang AHN; Poon TCW; Cheung E
EMBO Rep; 2022 Aug; 23(8):e53468. PubMed ID: 35785414
[TBL] [Abstract][Full Text] [Related]
30. CUL4A regulates endometrial cancer cell proliferation, invasion and migration by interacting with CSN6.
Wang X; Chen T
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179082
[TBL] [Abstract][Full Text] [Related]
31. Circ_0001273 downregulation inhibits the growth, migration and glutamine metabolism of esophageal cancer cells via targeting the miR-622/SLC1A5 signaling axis.
Wu B; Chen Y; Chen Y; Xie X; Liang H; Peng F; Che W
Thorac Cancer; 2022 Jun; 13(12):1795-1805. PubMed ID: 35567340
[TBL] [Abstract][Full Text] [Related]
32. B3GNT3 acts as a carcinogenic factor in endometrial cancer via facilitating cell growth, invasion and migration through regulating RhoA/RAC1 pathway-associated markers.
Wang JS; Ruan F; Guo LZ; Wang FG; Wang FL; An HM
Genes Genomics; 2021 May; 43(5):447-457. PubMed ID: 33683574
[TBL] [Abstract][Full Text] [Related]
33. Role of TRIM33 in Wnt signaling during mesendoderm differentiation.
Xia X; Zuo F; Luo M; Sun Y; Bai J; Xi Q
Sci China Life Sci; 2017 Oct; 60(10):1142-1149. PubMed ID: 28844090
[TBL] [Abstract][Full Text] [Related]
34. The Glutaminase Inhibitor Compound 968 Exhibits Potent
Guo H; Li W; Pan G; Wang C; Li D; Liu N; Sheng X; Yuan L
Anticancer Agents Med Chem; 2023; 23(2):210-221. PubMed ID: 35570522
[TBL] [Abstract][Full Text] [Related]
35. KIFC1 promotes aerobic glycolysis in endometrial cancer cells by regulating the c-myc pathway.
Zhou K; Lin J; Dai M; He Y; Xu J; Lin Q
J Bioenerg Biomembr; 2021 Dec; 53(6):703-713. PubMed ID: 34729671
[TBL] [Abstract][Full Text] [Related]
36. Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2.
Xiao D; Ren P; Su H; Yue M; Xiu R; Hu Y; Liu H; Qing G
Oncotarget; 2015 Dec; 6(38):40655-66. PubMed ID: 26528759
[TBL] [Abstract][Full Text] [Related]
37. Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1-mediated lipid accumulation.
Shi Z; Zhou Q; Gao S; Li W; Li X; Liu Z; Jin P; Jiang J
Life Sci; 2019 Jan; 217():70-80. PubMed ID: 30452972
[TBL] [Abstract][Full Text] [Related]
38. LncRNA NEAT1 promotes endometrial cancer cell proliferation, migration and invasion by regulating the miR-144-3p/EZH2 axis.
Wang W; Ge L; Xu XJ; Yang T; Yuan Y; Ma XL; Zhang XH
Radiol Oncol; 2019 Nov; 53(4):434-442. PubMed ID: 31747378
[TBL] [Abstract][Full Text] [Related]
39. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway.
Chen H; Wang Y; Xue F
Oncol Rep; 2013 Feb; 29(2):507-14. PubMed ID: 23135473
[TBL] [Abstract][Full Text] [Related]
40. SLC38A2 promotes cell proliferation and invasion by promoting glutamine metabolism in adenomyosis.
Wu K; Gong W; Hu JC; Duan YC; Ke HH; Chen L
Exp Ther Med; 2024 May; 27(5):218. PubMed ID: 38590564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
